Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease

Rory Wolfe, James B. Wetmore, Robyn L. Woods, John J. McNeil, Hugh Gallagher, Paul Roderick, Rowan G. Walker, Mark Nelson, Christopher M. Reid, Raj C. Shah, Michael E. Ernst, Jessica E. Lockery, Andrew Tonkin, Walter P. Abhayaratna, Peter Gibbs, Erica M. Wood, Suzanne E. Mahady, Jeff D. Williamson, Geoffrey A. Donnan, Geoffrey Cloud, Anne M. Murray, Kevan R. Polkinghorne